Beryl Drugs Ltd shares fall 1.32% as Exchange receives disclosure under SEBI Regulation 29(2) for Sudhir Sethi
Why did Beryl Drugs Ltd shares fall today?
Beryl Drugs Ltd shares fell by 1.32% today, Monday, closing at ₹22.5 by 3:41 PM. This decline came after the company made a disclosure to the stock exchange as required under SEBI regulations.
The disclosure, submitted under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, pertains to an announcement concerning Sudhir Sethi. In simple terms, this regulation requires companies to notify the exchange and investors when there is a significant change in the ownership or control of the company, such as a major investor acquiring or selling a large stake.
The market's reaction to such a disclosure can often lead to a change in the share price, as investors may interpret the news as a signal of a shift in the company's management or major shareholder structure. This filing regarding Sudhir Sethi likely triggered investor sentiment, contributing to the negative movement in the stock today.
What does Beryl Drugs Ltd do?
Beryl Drugs Ltd operates in the business sector involving the distribution of pharmaceutical and consumer health products. The company's core activities encompass the trading and marketing of these product categories.
Beryl Drugs Ltd Financials
In CroresBeryl Drugs Ltd's financials show a positive quarter-over-quarter trend, with revenue growing from ₹3.778 Crores in December 2025 to ₹5.13 Crores in March 2026, an increase of approximately 35.8%. Concurrently, the company's profit position improved significantly, moving from a net loss of ₹0.17 Crores to a net profit of ₹0.56 Crores.
Beryl Drugs Ltd Shareholding Pattern
Promoter holding stands at 27.82% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.0% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 72.19% stake in Beryl Drugs Ltd.
Beryl Drugs Ltd FAQs
Q: Why did Beryl shares fall 1.32% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Beryl Drugs Ltd?
As per the latest data, promoters hold 27.82% stake in Beryl Drugs Ltd, while FII holding stands at 0.0%. Domestic institutional investors hold 0.0%, and public shareholders account for 72.19% of the equity.
Q: What is the current stock price of Beryl Drugs Ltd?
Beryl Drugs Ltd shares are currently trading at ₹22.5, recording a decline of 1.32% from the previous close.
Q: What is the market capitalization of Beryl Drugs Ltd?
The company currently has a market capitalization of ₹11.41 crore, reflecting its valuation in the Indian equity market.